Atlas Trials

Alendronate to Reduce Pelvic Insufficiency Fractures in Cervical Cancer Patients Undergoing Chemoradiation

Clinical trial NCT07245381 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07245381
Sponsor
Dr. Itay GoorAryeh
Status
NOT_YET_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Cervix Cancer
Start date
2025-12-01
Primary completion
2026-08-01
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.